Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{200926,
        author = {Sakshi Ramesh Pisal and Mansi Shantaram Palsande and Rutuja Mansing Patil},
        title = {Transdermal Nanoparticle System For Anti-inflammatory Drug},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {12},
        number = {12},
        pages = {2337-2349},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=200926},
        abstract = {Inflammation is a natural immune response to infection or injury, but long-term inflammation can cause diseases such as autoimmune disorders, neurodegenerative diseases, and cancer. Many anti-inflammatory drugs like Aspirin and NSAIDs are available, and new treatments such as biological drugs, anti-cytokine therapies, and kinase inhibitors are being developed. Transdermal nanoparticle-based drug delivery systems are a promising method to improve treatment. Nanoparticles help drugs pass through the skin barrier, improve drug stability, and provide controlled drug release. This increases treatment effectiveness and reduces side effects. Nanoparticle-loaded Ibuprofen gels show better skin penetration, improved drug stability, and stronger anti-inflammatory effects compared to conventional formulations. Therefore, nanoparticle-based transdermal delivery systems are a promising approach for effective inflammation treatment. Future research will focus on developing safer and more advanced nanocarriers to improve drug delivery and patient compliance.},
        keywords = {Transdermal drug delivery, Nanoparticles, Anti-inflammatory drugs, Nanocarriers, skin, Permeation, Controlled drugs.},
        month = {May},
        }